Innovative smart pill bottles significantly enhance adherence to oral adjuvant endocrine therapy in early-stage breast cancer ...
Some experts believe the cancer label can be inappropriate for certain low-risk conditions and advocate dropping the C-word.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback